Anti-spike antibody response to the COVID vaccine in lymphoma patients

Patients with hematologic malignancies have poor outcomes from COVID infection and are less likely to mount an antibody response after COVID infection. This is a retrospective study of adult lymphoma patients who received the COVID vaccine between 12/1/2020 and 11/30/2021. The primary endpoint was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Della Pia, Alexandra, Kim, Gee Youn (Geeny), Ip, Andrew, Ahn, Jaeil, Liu, Yanzhi, Kats, Simone, Koropsak, Michael, Lukasik, Brittany, Contractor, Anamta, Amin, Krushna, Ayyagari, Lakshmi, Zhao, Charles, Gupta, Amolika, Batistick, Mark, Leslie, Lori A., Goy, Andre H., Feldman, Tatyana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714943/
https://www.ncbi.nlm.nih.gov/pubmed/36454941
http://dx.doi.org/10.1371/journal.pone.0266584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714943/
https://www.ncbi.nlm.nih.gov/pubmed/36454941
http://dx.doi.org/10.1371/journal.pone.0266584

Ejemplares similares